Werewolf Therapeutics (HOWL) News Today $1.45 +0.02 (+1.40%) Closing price 04:00 PM EasternExtended Trading$1.45 0.00 (0.00%) As of 04:40 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock HOWL Latest News All Sources Trusted Sources MarketBeat Barchart Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent September 2025 August 2025 July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 Time Period What is Leerink Partnrs' Forecast for HOWL Q3 Earnings?September 9, 2025 | marketbeat.comBrokers Offer Predictions for HOWL Q1 EarningsSeptember 7, 2025 | marketbeat.comBrokers Issue Forecasts for HOWL Q1 EarningsSeptember 7, 2025 | americanbankingnews.comWerewolf Therapeutics to Participate in the Upcoming H.C. Wainwright 27th Annual Global Investment ConferenceSeptember 2, 2025 | globenewswire.comBank of America Has Lowered Expectations for Werewolf Therapeutics (NASDAQ:HOWL) Stock PriceAugust 27, 2025 | marketbeat.comWerewolf Therapeutics price target lowered to $3 from $4 at Citizens JMPAugust 22, 2025 | msn.comWhat is HC Wainwright's Estimate for HOWL Q3 Earnings?August 19, 2025 | marketbeat.comWerewolf Therapeutics (NASDAQ:HOWL) Posts Earnings Results, Beats Expectations By $0.10 EPSAugust 18, 2025 | marketbeat.comWerewolf Therapeutics Faces Regulatory and Financial Challenges Amid FDA DisruptionsAugust 16, 2025 | msn.comWerewolf Therapeutics Reports Q2 2025 Financial ResultsAugust 14, 2025 | tipranks.comWerewolf Therapeutics sees cash runway into 4Q26August 14, 2025 | msn.comWerewolf Therapeutics Reports Q2 2025 Financial ResultsAugust 14, 2025 | msn.comWerewolf Therapeutics Reports Second Quarter 2025 Financial Results and Provides Business UpdateAugust 14, 2025 | globenewswire.comWerewolf Therapeutics (HOWL) Projected to Post Earnings on ThursdayAugust 7, 2025 | marketbeat.comWerewolf Therapeutics (NASDAQ:HOWL) Trading Up 0.8% - Time to Buy?August 1, 2025 | marketbeat.comReAlta Life Sciences Appoints Ellen Lubman as Chief Business OfficerJuly 29, 2025 | finance.yahoo.comHowling Hits: The Ultimate List of Must-Watch Werewolf MoviesJuly 17, 2025 | msn.comWerewolf Therapeutics to Participate in the KidneyCAN 7th Annual Kidney Cancer Research SummitJuly 9, 2025 | globenewswire.comWerewolf Therapeutics, Inc. (HOWL) - Yahoo FinanceJuly 3, 2025 | finance.yahoo.comWerewolf Therapeutics to Participate in the BIO International ConventionJune 12, 2025 | globenewswire.comWerewolf Therapeutics, Inc. (NASDAQ:HOWL) Shares Sold by Millennium Management LLCJune 6, 2025 | marketbeat.comWerewolf Therapeutics to Participate in the Upcoming Jefferies Global Healthcare ConferenceMay 29, 2025 | globenewswire.comWerewolf Therapeutics’ SWOT analysis: innovative platform drives stock potentialMay 24, 2025 | investing.comWerewolf Therapeutics Stock Price, Quotes and ForecastsMay 20, 2025 | benzinga.comHonorHealth Research Institute patient with advanced skin cancer in remission for more than a year following clinical trial of Werewolf Therapeutics' investigational novel conditionally activated IL-2 pro-drug WTX-124May 20, 2025 | globenewswire.comWerewolf Therapeutics, Inc. (NASDAQ:HOWL) Director Acquires $159,288.22 in StockMay 15, 2025 | insidertrades.comWerewolf Therapeutics to Participate in Hanson Wade's 6th Annual Cytokine-Based Drug Development SummitMay 13, 2025 | globenewswire.comWerewolf Therapeutics, Inc.: Werewolf Therapeutics Reports First Quarter 2025 Financial Results and Provides Business UpdateMay 9, 2025 | finanznachrichten.deWerewolf Therapeutics Announces Q1 2025 Financial ResultsMay 9, 2025 | msn.comWerewolf Therapeutics Reports First Quarter 2025 Financial Results and Provides Business UpdateMay 8, 2025 | globenewswire.comWerewolf Therapeutics reports progress on IBD treatmentMay 6, 2025 | investing.comWerewolf Therapeutics to Participate in Upcoming Investor ConferencesMay 5, 2025 | globenewswire.comWerewolf Therapeutics appoints Bloom as Chief Business OfficerApril 17, 2025 | markets.businessinsider.comWerewolf Therapeutics Appoints Steven Bloom as Chief Business OfficerApril 17, 2025 | globenewswire.comWatch: First dire wolf’s howl for 10,000 years after scientists bring extinct species ‘back to life’April 8, 2025 | msn.comWerewolf Therapeutics to Present at the 24th Annual Needham Virtual Healthcare ConferenceMarch 31, 2025 | globenewswire.comWerewolf Therapeutics (HOWL) Gets a Buy from Bank of America SecuritiesMarch 28, 2025 | markets.businessinsider.comWedbush Research Analysts Cut Earnings Estimates for HOWLMarch 17, 2025 | marketbeat.comHC Wainwright Issues Pessimistic Outlook for HOWL EarningsMarch 17, 2025 | marketbeat.comAnalysts Are Bullish on Top Healthcare Stocks: Werewolf Therapeutics (HOWL), Exelixis (EXEL)March 13, 2025 | markets.businessinsider.comWerewolf Therapeutics' (HOWL) Outperform Rating Reiterated at WedbushMarch 13, 2025 | marketbeat.comWerewolf Therapeutics' (HOWL) "Buy" Rating Reiterated at HC WainwrightMarch 13, 2025 | marketbeat.comWerewolf Therapeutics (NASDAQ:HOWL) Posts Quarterly Earnings Results, Misses Estimates By $0.03 EPSMarch 12, 2025 | marketbeat.comWerewolf Therapeutics (NASDAQ:HOWL) Issues Quarterly Earnings Results, Misses Expectations By $0.03 EPSMarch 12, 2025 | marketbeat.comWerewolf Therapeutics Faces Geopolitical Risks Amid Changing Trade Policies with ChinaMarch 12, 2025 | tipranks.comWerewolf Therapeutics Reports 2024 Financial Results and ProgressMarch 11, 2025 | tipranks.comWerewolf Therapeutics reports Q4 EPS (46c), consensus (31c)March 11, 2025 | markets.businessinsider.comWerewolf Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business UpdateMarch 11, 2025 | globenewswire.comWerewolf Therapeutics to Present at the 2025 Leerink Partners Global Biopharma ConferenceMarch 4, 2025 | globenewswire.comWerewolf Therapeutics (HOWL) Expected to Announce Quarterly Earnings on ThursdayFebruary 27, 2025 | marketbeat.com Get Werewolf Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for HOWL and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. HOWL Media Mentions By Week HOWL Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. HOWL News Sentiment▼1.730.92▲Average Medical News Sentiment HOWL News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. HOWL Articles This Week▼12▲HOWL Articles Average Week Get the Latest News and Ratings for HOWL and Related Stocks Enter your email address to receive the latest news and analysts' ratings for Werewolf Therapeutics and its competitors. Sign Up View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Related Companies and Tools Related Companies DBV Technologies News Prima BioMed News Annexon News Voyager Therapeutics News Lyell Immunopharma News Alpha Teknova News Tonix Pharmaceuticals News Sagimet Biosciences News AC Immune News Aclaris Therapeutics News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:HOWL) was last updated on 9/16/2025 by MarketBeat.com Staff From Our PartnersWhy More Investors Are Using Family Trusts to Protect Their WealthFor many investors, a family trust can be an essential tool for protecting assets, avoiding probate, and ensur...SmartAsset | SponsoredFanatics Hit $31B-Is This Nasdaq Next?Fanatics built an empire by owning the fan experience-scaling to a $31B valuation. But the next wave isn't abo...i2i Marketing Group, LLC | SponsoredNvidia Times 1,000,000Nvidia’s latest AI chip is a $25,000 powerhouse — with 80 billion transistors and the ability to perform 60 tr...Paradigm Press | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredCrypto Gets Official Government Backing—Here's the WinnerTrump Just Signed the GENIUS Act—One Coin is About to Explode We're at the BEGINNING of smart money really ...Crypto 101 Media | SponsoredOpenAI’s new $300 billion dealOpenAI just signed a $300 billion cloud deal with Oracle to secure the computing power needed for its next Cha...Porter & Company | SponsoredNvidia CEO Makes First Ever Tesla AnnouncementWhile headlines focus on Tesla’s car sales, tech analyst Jeff Brown says the real story is Tesla’s role in a $...Brownstone Research | SponsoredCollege grad makes $64,000 a monthA Wall Street legend just helped train our own proprietary AI system in the stock market (a project that took ...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Werewolf Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Werewolf Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
